The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
Paves way for CNS cancer test rollout
Subscribe To Our Newsletter & Stay Updated
